Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy and safety of different doses of
pramipexole (Sifrol) on subjective and objective symptoms of idiopathic Restless Legs
Syndrome (RLS) and also to determine the optimal dose of pramipexole in patients with RLS by
polysomnography and evaluation of clinical improvement.